|
1
|
Cancer Stat Facts: Prostate Cancer in
2018; Available from: https://seer.cancer.gov/statfacts/html/prost.html.
|
|
2
|
World Cancer Report 2014. World Health
Organization. 2014. pp. Chapter 5.11.
|
|
3
|
Caini S, Gandini S, Dudas M, Bremer V,
Severi E and Gherasim A: Sexually transmitted infections and
prostate cancer risk: A systematic review and meta-analysis. Cancer
Epidemiol. 38:329–338. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Miller DC, Hafez KS, Stewart A, Montie JE
and Wei JT: Prostate carcinoma presentation, diagnosis, and
staging: An update form the national cancer data base. Cancer.
98:1169–1178. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Redman JM, Gulley JL and Madan RA:
Combining immunotherapies for the treatment of prostate cancer.
Urol Oncol. 35:694–700. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jang TL, Kim IY, Scardino PT and Eastham
JA: Reply to effectiveness of radical prostatectomy with adjuvant
radiotherapy versus radiotherapy plus androgen deprivation therapy
for men with advanced prostate cancer: Do we have certainties
today? Cancer. 125:2318–2320. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms?
Trends Cell Biol. 17:118–126. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
O'Hara SP, Mott JL, Splinter PL, Gores GJ
and LaRusso NF: MicroRNAs: Key modulators of posttranscriptional
gene expression. Gastroenterology. 136:17–25. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang XJ, Reyes JL, Chua NH and Gaasterland
T: Prediction and identification of arabidopsis thaliana microRNAs
and their mRNA targets. Genome Biol. 5(R65)2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
He J, Sun M, Geng H and Tian S: Long
non-coding RNA Linc00518 promotes paclitaxel resistance of the
human prostate cancer by sequestering miR-216b-5p. Biol Cell.
111:39–50. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liang YK, Han ZD, Lu JM, Liu ZZ, Zhuo YJ,
Zhu XJ, Chen JX, Ye JH, Liang YX, He HC and Zhong WD:
Downregulation of ARID4A and ARID4B promote tumor progression and
directly regulated by microRNA-30d in patient with prostate cancer.
J Cell Biochem. 119:7245–7255. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jiang W, Gao Y, Wang Z, Gong C, Hu C, Ding
X, Qiang L, Gao S and Ren F: Co-delivery of miR-4638-5p and
docetaxel based on redox-sensitive polypeptide micelles as an
improved strategy for the treatment of castration-resistant
prostate cancer. Mol Pharm. 16:437–447. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Khorasani M, Teimoori-Toolabi L, Farivar
TN, Asgari M, Abolhasani M, Shahrokh H, Afgar A, Kalantari E,
Peymani A and Mahdian R: Aberrant expression of miR-141 and nuclear
receptor small heterodimer partner in clinical samples of prostate
cancer. Cancer Biomark. 22:19–28. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Aboobaker AA, Tomancak P, Patel N, Rubin
GM and Lai EC: Drosophila microRNAs exhibit diverse spatial
expression patterns during embryonic development. Proc Natl Acad
Sci USA. 102:18017–18022. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wu X, Ding X, Ding Z and Jia P: Total
flavonoids from leaves of carya cathayensis ameliorate renal
fibrosis via the miR-21/Smad7 signaling pathway. Cell Physiol
Biochem. 49:1551–1563. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wu G, Liu J, Wu Z, Wu X and Yao X:
MicroRNA-184 inhibits cell proliferation and metastasis in human
colorectal cancer by directly targeting IGF-1R. Oncol Lett.
14:3215–3222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fang Z, Zhao J, Xie W, Sun Q, Wang H and
Qiao B: LncRNA UCA1 promotes proliferation and cisplatin resistance
of oral squamous cell carcinoma by suppressing miR-184 expression.
Cancer Med. 6:2897–2908. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Qadir M and Faheem A: mRNA: A diagnostic
and therapeutic tool for pancreatic cnacer. Crit Rev Eukaryot Gene
Expr. 27:197–204. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liang M, Sun Y, Yang HL, Zhang B, Wen J
and Shi BK: DLX1, a binding protein of beta-catenin, promoted the
growth and migration of prostate cancer cells. Exp Cell Res.
363:26–32. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li JY, Wei X, Sun Q, Zhao XQ, Zheng CY,
Bai CX, Du J, Zhang Z, Zhu LG and Jia YS: MicroRNA-449b-5p promotes
the progression of osteoporosis by inhibiting osteogenic
differentiation of BMSCs via targeting Satb2. Eur Rev Med Pharmacol
Sci. 23:6394–6403. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gironella M, Seux M, Xie MJ, Cano C,
Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, et
al: Tumor protein 53-induced nuclear protein 1 expression is
repressed by miR-155, and its restoration inhibits pancreatic tumor
development. Proc Natl Acad Sci USA. 104:16170–16175.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Akao Y, Nakagawa Y and Naoe T: MicroRNAs
143 and 145 are possible common onco-microRNAs in human cancers.
Oncol Rep. 16:845–850. 2006.PubMed/NCBI
|
|
25
|
Neilson JR, Zheng GX, Burge CB and Sharp
PA: Dynamic regulation of miRNA expression in ordered stages of
cellular development. Genes Dev. 21:578–589. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen XM, Splinter PL, O'Hara SP and
LaRusso NF: A cellular micro-RNA, let-7i, regulates Toll-like
receptor 4 expression and contributes to cholangiocyte immune
responses against cryptosporidium parvum infection. J Biol Chem.
282:28929–28938. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Su Z, Chen D, Li Y, Zhang E, Yu Z, Chen T,
Jiang Z, Ni L, Yang S, Gui Y, et al: microRNA-184 functions as
tumor suppressor in renal cell carcinoma. Exp Ther Med. 9:961–966.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Feng L, Ma J, Ji H, Liu Y and Hu W:
MiR-184 retarded the proliferation, invasiveness and migration of
glioblastoma cells by repressing stanniocalcin-2. Pathol Oncol Res.
24:853–860. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Phua YW, Nguyen A, Roden DL, Elsworth B,
Deng N, Nikolic I, Yang J, Mcfarland A, Russell R, Kaplan W, et al:
MicroRNA profiling of the pubertal mouse mammary gland identifies
miR-184 as a candidate breast tumour suppressor gene. Breast Cancer
Res. 17(83)2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen D, Li J, Li S, Han P, Li N, Wang Y
and Du S: miR-184 promotes cell proliferation in tongue squamous
cell carcinoma by targeting SOX7. Oncol Lett. 16:2221–2228.
2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Schneider JA and Logan SK: Revisiting the
role of Wnt/β-catenin signaling in prostate cancer. Mol Cell
Endocrinol. 462:3–8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chan DW, Hui WW, Wang JJ, Yung MMH, Hui
LMN, Qin Y, Liang RR, Leung THY, Xu D, Chan KKL, et al: DLX1 acts
as a crucial target of FOXM1 to promote ovarian cancer
aggressiveness by enhancing TGF-β/SMAD4 signaling. Oncogene.
36:1404–1416. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sabóia TM, Reis MF, Martins AM, Romanos
HF, Tannure PN, Granjeiro JM, Vieira AR, Antunes LS, Küchler EC and
Costa MC: DLX1 and MMP3 contribute to oral clefts with and without
positive family history of cancer. Arch Oral Biol. 60:223–228.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Leyten GH, Hessels D, Smit FP, Jannink SA,
de Jong H, Melchers WJ, Cornel EB, de Reijke TM, Vergunst H, Kil P,
et al: Identification of a candidate gene panel for the early
diagnosis of prostate cancer. Clin Cancer Res. 21:3061–3070.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rhie SK, Guo Y, Tak YG, Yao L, Shen H,
Coetzee GA, Laird PW and Farnham PJ: Identification of activated
enhancers and linked transcription factors in breast, prostate, and
kidney tumors by tracing enhancer networks using epigenetic traits.
Epigenetics Chromatin. 9(50)2016.PubMed/NCBI View Article : Google Scholar
|
